AKT1 and thyroid gland carcinoma: Furthermore, miR‐133a‐3p can regulate the PI3K/AKT/mTOR signaling pathway in thyroid cancer by modulating ZEB1‐AS1 and targeting LPAR3 and EGFR, inhibiting thyroid cancer cell proliferation while promoting cell death.26